We designed an autocrine scFv PD-L1 antibody to study if binding of scFv PD-L1 antibody to the PD-L1 positive Nalm6 B-ALL and HCC1954 breast cancer cells can affect CAR T cell functions. This evidence concerns the gene CD274 and breast cancer.